Sabichi, Anita L <br/><br/>
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jan 2008 
 - 224-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-07-0733  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>BCG Vaccine--administration & dosage<br/>Carcinoma, Transitional Cell--pathology<br/>Female<br/>Fenretinide--therapeutic use<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--prevention & control<br/>Placebos<br/>Survival Analysis<br/>Urinary Bladder Neoplasms--pathology